NOD mice spontaneously develop Type 1 Diabetes (T1D) due to a loss of T cell tolerance to islet antigens. Congenic strains of NOD mice that are highly protected from the occurrence of T1D, because they have multiple resistance alleles situated on two chromosomes (ldd3/5 mice) or 3 linked resistance alleles on a single chromosome (Idd9), do not harbor high-avidity, islet-specific CDS T cells. In order to delineate the mechanism by which CDS tolerance is restored, we will trace the path of naive, islet-specific CDS cells in situations where resistance alleles at multiple or single Idd loci are expressed only in particular cell types. This will provide an assay that will identify the cell(s) that must express specific protective Idd genes to achieve CDS tolerance. We will then correlate gene expression of candidate Idd genes within the relevant cell populations obtained from NOD or congenic mice with the functional consequences that relate to protection from autoimmunity. Although four of the subregions, Idd3, Idd5.1, Idd5.2 and Idd9.3 are relatively well-characterized and the likely molecular basis of disease susceptibility is known in each case, Idd5.3, Idd9.2, and Idd9.1 require further efforts to positionally clone the Idd genes. Relevance: The occurrence of T1D in humans and mice has been mapped to a number of genetic susceptibility loci that prevent T cell tolerance to islet antigens. By elucidating naturally occurring mechanisms that restore such tolerance (as defined by Idd genes that prevent disease), we will better understand the etiology of the disease and also identify targets for interventions that can be used to prevent T1D.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01AI070351-03S1
Application #
7890853
Study Section
Special Emphasis Panel (ZAI1-MP-I (M1))
Program Officer
Esch, Thomas R
Project Start
2009-08-01
Project End
2011-07-31
Budget Start
2009-08-01
Budget End
2011-07-31
Support Year
3
Fiscal Year
2009
Total Cost
$625,000
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Fraser, Heather I; Howlett, Sarah; Clark, Jan et al. (2015) Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic Mice. J Immunol 195:4841-52
Maine, Christian J; Marquardt, Kristi; Scatizzi, John C et al. (2015) The effect of the autoimmunity-associated gene, PTPN22, on a BXSB-derived model of lupus. Clin Immunol 156:65-73
Maine, Christian J; Marquardt, Kristi; Cheung, Jocelyn et al. (2014) PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells. J Immunol 192:1415-24
Kochupurakkal, Nora M; Kruger, Annie J; Tripathi, Sudipta et al. (2014) Blockade of the programmed death-1 (PD1) pathway undermines potent genetic protection from type 1 diabetes. PLoS One 9:e89561
Lin, Xiaotian; Hamilton-Williams, Emma E; Rainbow, Daniel B et al. (2013) Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes. J Immunol 190:3109-20
Hamilton-Williams, Emma E; Rainbow, Daniel B; Cheung, Jocelyn et al. (2013) Fine mapping of type 1 diabetes regions Idd9.1 and Idd9.2 reveals genetic complexity. Mamm Genome 24:358-75
Hamilton-Williams, Emma E; Cheung, Jocelyn; Rainbow, Daniel B et al. (2012) Cellular mechanisms of restored ?-cell tolerance mediated by protective alleles of Idd3 and Idd5. Diabetes 61:166-74
Maine, Christian J; Hamilton-Williams, Emma E; Cheung, Jocelyn et al. (2012) PTPN22 alters the development of regulatory T cells in the thymus. J Immunol 188:5267-75
Yamanouchi, Jun; Puertas, Maria-Carmen; Verdaguer, Joan et al. (2010) Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells. Diabetes 59:272-81
Hamilton-Williams, Emma E; Wong, S B Justin; Martinez, Xavier et al. (2010) Idd9.2 and Idd9.3 protective alleles function in CD4+ T-cells and nonlymphoid cells to prevent expansion of pathogenic islet-specific CD8+ T-cells. Diabetes 59:1478-86

Showing the most recent 10 out of 11 publications